About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Testing Effect and Schizophrenia

Testing Effect and Schizophrenia

NCT02150174·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University Hospital, Strasbourg, France

Age

18–60

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

French is the native language, or acquired before 5 years old
People must be able to understand and follow the trial instructions
Diagnostic of schizophrenia, according to the DSM -5, clinically stable
The treatment must remain unchanged during the trial

You may not be if

Severe or acute cerebral disease
Other actual psychiatric disorder
Use of drugs with high anticholinergic effect
Irregular use of benzodiazepines medication, or high dose of benzodiazepin (more than 2 mg of lorazepam per day or equivalent)
Inappropriate use of drugs
\- Diagnostic of schizophrenia of a relative up to the third degree

The record

StatusCompleted

PhaseNo phase

Taking part40

StartedJul 2014

UpdatedDec 22, 2025

Conditions

Schizophrenia Episodic Memory Deficits

Where2

Centre Psychothérapique de Nancy
Laxou, France
Service de psychiatrie - Hôpital Civil - CHRU Strasbourg
Strasbourg, France